Real World Experience

Russo Partners has a history. From the evolution of biotech to the launch of pharmaceutical marketing 2.0, we have been there every step of the way.

We’re not all talk. PR isn’t just about getting a message out. It’s getting the right message to the right people at the right time. At Russo Partners, we do just that – and so much more.

Home

Introducing our new Sports-Health Alliance.

We develop award-winning PR programs that are at the intersection of health, medicine, and sports. We call on our cadre of athletes, broadcasters and sports business leaders with whom we have close relationships and share the passions of our clients

Learn more about how this strategic approach is shifting perceptions of our clients and their products, fueling their clinical trial enrollment, and doing much, much more

 

At Russo Partners, communications counselors with PhDs, MDs, JDs and MBAs roll up their sleeves to implement integrated programs for biopharma, medtech, diagnostics, healthcare IT and healthcare services companies worldwide.

Since our founding as Noonan/Russo more than 25 years ago, we’ve been on a first-name basis with the people you need to be talking to. Which means you should be talking to us.

Latest News

 

Jul
26

Curis to Release Second Quarter 2017 Financial Results and Hold Conference Call on August 3, 2017

LEXINGTON, Mass., July 26, 2017 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercializationREAD MORE…

Jul
26

Vericel to Host Second-Quarter 2017 Earnings Webcast and Conference Call on August 9, 2017

CAMBRIDGE, Mass., July 26, 2017 (GLOBE NEWSWIRE) — Vericel Corporation (VCEL), a leading developer of autologous expanded cell therapies forREAD MORE…

Jul
24

Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs

GAITHERSBURG, Md., July 24, 2017 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq:NVAX) today announced positive topline data from its Phase 2 safety and immunogenicity trialREAD MORE…

Twitter Stream